Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Deglutition × Head & Neck × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Deglutition Disorders 1

Interventions

Cisplatin 143 Radiotherapy 71 Fluorouracil 50 Radiotherapy, Intensity-Modulated 45 Docetaxel 39 Cetuximab 38 Gemcitabine 37 Carboplatin 31 pembrolizumab 25 Capecitabine 21 Drug Therapy 17 Paclitaxel 14 toripalimab 13 camrelizumab 10 Surgical Procedures, Operative 10 Nivolumab 10 Chemoradiotherapy 10 nimotuzumab 9 Radiation 8 Neoadjuvant Therapy 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Chemotherapy, Adjuvant 8 nedaplatin 7 Thyrotropin Alfa 7 Platinum 7 tislelizumab 6 spartalizumab 6 Standard of Care 6 Specimen Handling 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05187091 2026-04-15

SWOAR

All India Institute of Medical Sciences

Phase 3 Active not recruiting

Deglutition Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡